Opaleye Management Inc. 13D and 13G filings for Ocular Therapeutix, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 06:46 am Sale |
2024-12-31 | 13G | Ocular Therapeutix, Inc. OCUL |
Opaleye Management Inc. | 4,342,500 2.760% |
-1,727,500 (-28.46%) |
Filing |
| 2024-02-14 7:48 pm Sale |
2023-12-31 | 13G | Ocular Therapeutix, Inc. OCUL |
Opaleye Management Inc. | 6,070,000 5.510% |
-5,000 (-0.08%) |
Filing |
| 2023-02-13 06:11 am Purchase |
2022-12-30 | 13G | Ocular Therapeutix, Inc. OCUL |
Opaleye Management Inc. | 6,075,000 7.890% |
100,200 (+1.68%) |
Filing |
| 2022-01-31 8:38 pm Sale |
2021-12-31 | 13G | Ocular Therapeutix, Inc. OCUL |
Opaleye Management Inc. | 5,974,800 7.800% |
-535,200 (-8.22%) |
Filing |
| 2021-02-12 5:20 pm Purchase |
2020-12-31 | 13G | Ocular Therapeutix, Inc. OCUL |
Opaleye Management Inc. | 6,510,000 8.650% |
1,384,000 (+27.00%) |
Filing |